Forum Topics CGS CGS News

Pinned straw:

Added 11 months ago

For those of you interested in Donenemab by Eli Lilly: see below. Certainly looks like a better treatment option as less frequent dosing.


https://endpts.com/lillys-alzheimers-drug-donanemab-succeeds-in-phase-iii-trial/

UncleWally
11 months ago

Great news and a positive reaction by the market too.



15

edgescape
11 months ago

The story about the drug was on 7 news last night. Should be a good day today but such a topsy-turvy ride holding this!

20